Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice.

Cold Spring Harbor Perspectives in Medicine
Michael A BrehmDale L Greiner

Abstract

Despite decades of studying rodent models of type 1 diabetes (T1D), no therapy capable of preventing or curing T1D has successfully been translated from rodents to humans. This inability to translate otherwise promising therapies to clinical settings likely resides, to a major degree, from significant species-specific differences between rodent and human immune systems as well as species-related variances in islets in terms of their cellular composition, function, and gene expression. Indeed, taken collectively, these differences underscore the need to define interactions between the human immune system with human β cells. Immunodeficient mice engrafted with human immune systems and human β cells represent an interesting and promising opportunity to study these components in vivo. To meet this need, years of effort have been extended to develop mice depleted of undesirable components while at the same time, allowing the introduction of constituents necessary to recapitulate physiological settings as near as possible to human T1D. With this, these so-called "humanized mice" are currently being used as a preclinical bridge to facilitate identification and translation of novel discoveries to clinical settings.

References

Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·Z J ZhangH L Weiner
Dec 23, 1988·Science·R NamikawaJ M McCune
Mar 1, 1988·The Journal of Experimental Medicine·G C BosmaM J Bosma
Feb 10, 1983·Nature·G C BosmaM J Bosma
Jan 17, 1995·Proceedings of the National Academy of Sciences of the United States of America·J P DiSantoK Rajewsky
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·D L EizirikA Andersson
Mar 11, 1998·Lancet·E F LampeterH Kolb
Jun 9, 1998·Stem Cells·D L GreinerL D Shultz
Jun 17, 1999·Nature Medicine·M A Atkinson, E H Leiter
Oct 18, 2000·Proceedings of the National Academy of Sciences of the United States of America·M RistowC R Kahn
Jun 21, 2001·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·E SarugeriE Bonifacio
Jul 24, 2001·Clinical Immunology : the Official Journal of the Clinical Immunology Society·D L GreinerJ P Mordes
Feb 21, 2002·The Journal of Clinical Investigation·David Ron
May 1, 2002·Transplantation·Clayton E MathewsEdward H Leiter
Jan 24, 2003·Diabetes·Tetsuro IzumiToshiyuki Takeuchi
Aug 20, 2003·The Journal of Clinical Investigation·Michael RistowAndreas F H Pfeiffer
Dec 5, 2003·Seminars in Pediatric Neurology·Massimo Pandolfo
Jul 13, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jianxin XieH Franklin Bunn
Aug 17, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Scott J BanuelosMichael C Appel
Dec 25, 2004·Diabetologia·A G S van HalterenB O Roep
Dec 29, 2004·The Kaohsiung Journal of Medical Sciences·Cheng-Chong ChouBai-Hsiun Chen
Jun 29, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Hitoshi MinamiguchiMakio Ogawa
Feb 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Over CabreraAlejandro Caicedo
Oct 24, 2006·Nature Medicine·Michael W MelkusJ Victor Garcia

❮ Previous
Next ❯

Citations

May 8, 2013·Trends in Endocrinology and Metabolism : TEM·Scott A Soleimanpour, Doris A Stoffers
Jun 14, 2013·Journal of Diabetes Research·Lesya NovikovaLisa Stehno-Bittel
Nov 14, 2014·Diabetes·Glen R GallagherJennifer P Wang
Apr 12, 2016·The Journal of Clinical Investigation·Chunhua DaiAlvin C Powers
May 9, 2015·Pediatric Diabetes·Joseph G Daft, Robin G Lorenz
Jun 3, 2015·Inflammatory Bowel Diseases·Iurii KobozievMatthew B Grisham
Jan 27, 2015·Cell Transplantation·Hui-Ping LinShinn-Zong Lin
Mar 4, 2015·The EMBO Journal·Bjarki JohannessonDieter Egli
Jul 17, 2019·Clinical and Experimental Immunology·L PetersT M Brusko
Dec 29, 2019·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Frances T LeeXunrong Luo
Apr 21, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hanzhou WangXiao-Dong Chen
Jan 14, 2017·Frontiers in Physiology·Kyle C A WedgwoodKrasimira Tsaneva-Atanasova
Apr 17, 2020·Frontiers in Cell and Developmental Biology·Tine TesovnikTadej Battelino
Aug 2, 2017·Journal of Diabetes Research·Yuewen HanZhijia Ye
Jan 10, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sambra D RedickAgata Jurczyk

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

Annals of the New York Academy of Sciences
Leonard D ShultzDale L Greiner
Annals of the New York Academy of Sciences
Dale L GreinerLeonard D Shultz
Cellular & Molecular Immunology
Michael A Brehm, Leonard D Shultz
The Journal of Infectious Diseases
Michael A BrehmDale L Greiner
Cellular & Molecular Immunology
M Firoz MianAli A Ashkar
© 2021 Meta ULC. All rights reserved